News

Cannabis and hallucinogen use among adults continued to reach historic highs in 2023, according to the latest findings from the NIH-supported Monitoring the Future (MTF) survey.

Researchers from the University of Cincinnati, Ohio, suggest that increasing levels of the brain protein amyloid-β 42 may slow cognitive decline in Alzheimer’s disease.

Approval has been granted by the FDA for lebrikizumab-lbkz in treating moderate to severe atopic dermatitis in patients aged 12 and older.

Protective cells can be converted into tumor promoters after the immune system has been hijacked by cancer.

Researchers have uncovered a critical mechanism behind why certain viral infections, such as COVID-19, lead to lasting lung damage.

Emerging research has linked COVID-19 to joint pain and osteoarthritis, but the precise mechanisms behind this connection and the damage to articular cartilage were previously unclear.

The effects of radiotherapy on patients with systemic sclerosis (SSc) who develop cancer is a subject of growing concern due to the potential exacerbation of SSc symptoms and the risks of radiotherapy-related toxicity.

Stiff-person syndrome is a rare and disabling autoimmune disorder that presents evolving diagnostic challenges for clinicians.